• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

RXi Pharmaceuticals Corp

+ Add to Watchlist

RXII:US

1.6000 USD 0.00000.00%

As of 20:10:00 ET on 12/26/2014.

Company Profile for RXi Pharmaceuticals Corp (RXII)

RXi Pharmaceuticals Corp. is a biotechnology company focused on discovering, developing and commercializing therapies addressing major unmet medical needs using RNAi-targeted technologies. The Company's proprietary RNA interference ("RNAi"), is a naturally occurring cellular mechanism that interferes with or silences expression of targeted disease-associated genes.

Contact Information

RXi Pharmaceuticals Corp

60 Prescott Street
Worcester, MA 01605
United States
Phone: 1-508-767-3861

Key Executives for RXi Pharmaceuticals Corp (RXII)

Geert CauwenberghPresident/CEO/Acting CFOPamela A PavcoChief Development Officer

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil